BVF »

Pieris Pharmaceuticals shares owned by BVF

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by BVF from 13F filings

Historical chart of BVF investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by BVF

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 258k 16.74
2024-06-30 $2.5M 258k 9.88

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals (MIRM)
Tyra Biosciences (TYRA)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Cullinan Oncology (CGEM)
Xoma Royalty Corporation Com New (XOMA)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
4d Molecular Therapeutics In (FDMT)
Ac Immune Sa SHS (ACIU)
Gh Research Ordinary Shares (GHRS)
Kura Oncology (KURA)

View all positions for BVF

Top funds holding Pieris Pharmaceuticals

BVF
BML Capital Management
Lynx1 Capital Management
Renaissance Technologies
CM Management
Frazier Life Sciences Management
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Group
Acadian Asset Management
Citigroup
Tower Research Capital
Group One Trading

View all funds holding Pieris Pharmaceuticals